Two cases of allergic urticaria induced by insulin degludec and liraglutide injection
Two female patients received insulin degludec and liraglutide injection and developed allergic urticaria after 1 day and 2 days respectively.The drug was discontinued and other insulin was used for glucose-lowering therapy,and anti-allergy treatment was administered with dexamethasone,cetirizine and topical cream,then two patients'symptoms gradually improved.The results of the association between the two adverse drug reactions and insulin degludec and liraglutide injection were"probably relevant".According to the domestic and foreign literature,there were rare reports of allergic urticaria in diabetic patients using insulin degludec and liraglutide injection.By analyzing the clinical characteristics of the two cases of adverse drug reactions,the role of clinical pharmacists in judging allergens and participating in the adjustment of hypoglycemic regimens is explored,which provides reference for individualized clinical medication and safe medication.
Insulin degludec and liraglutide injectionCompound preparationAllergic urticariaAdverse drug reaction
万方数据
维普
